ClinicalTrials.gg
CompletedNCT03316495Updated Oct 20, 2017

IMPACT OF PAMPHLET ON THE KNOWLEDGE OF HEALTH EFFECT OF SMOKING

An interventional study of PAMPHLET in Tobacco Use Cessation, sponsored by University of Benin. Completed at 1 site in Nigeria. Open to participants aged 16 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-10-20.

Sponsored by University of Benin · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Mar 2017, registered Oct 2017).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
16 Years to 40 Years
Sex
All
01

Study summary

Tobacco smoke is one of the most preventable cause of mortality and morbidity worlwide, this study is conducted to compare the knowledge of the health effects of smoking among undergraduates exposed and those not exposed to educational pamphlet. This is designed as a randomized clinical trial among 390 undergraduate in University of Benin Edo State Nigeria. Data collection tool was an interviewer-administered questionnaire. Data obtained would be subjected to regression statistics using IBM SPSS version 21.0. The expected outcome will be a veritable tool in tobacco cessation model.

02

Conditions studied

  • Tobacco Use Cessation

Browse trials for

03

In context

Tobacco Use Cessation

276 studies on the registry are indexed under Tobacco Use Cessation; 45 are open to participants now.

This study's enrollment of 400 is above the median of 226 across 256 interventional studies indexed under Tobacco Use Cessation.

Browse Tobacco Use Cessation studies →

Lead sponsor

University of Benin is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • HEALTHY

Exclusion criteria

Exclusion Criteria:

  • NOT CONSENTING
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
400 participants (actual)

Study arms

  • No intervention
    without pamphlet

    NOT EXPOSED TO PAMPHLETS

  • Experimental
    with pamphlet

    EXPOSED TO PAMPHLETS

    Behavioral: PAMPHLET

Interventions

  • BehavioralPAMPHLET

    EXPOSURE TO PAMPHLETS

06

What researchers measure

Primary outcomes

  1. KNOWLEDGE OF HEALTH EFFECT OF SMOKING

    QUESTIONNAIRE

    Time frame: 7 MONTHS

07

Study locations

1 site
  • Clement Chinedu Azodo
    Benin City, Edo State 300001, Nigeria
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2017 to primary completion in Sep 2017, 6 months.

Of 115 non-industry interventional studies with no phase under Tobacco Use Cessation, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 40. This study's 6 months is below that.

Counting every sponsor, half of 116 studies reached it within 24 months; a quarter within 15 and three quarters within 40.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 17, 2017
First posted
Oct 20, 2017
StartActual
Mar 1, 2017
Primary completionActual
Sep 30, 2017
CompletionActual
Oct 3, 2017
Last update
Oct 20, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 20, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03316495
Lead sponsor
University of Benin
Collaborators
UBTH
Responsible party
Clement Chinedu Azodo (Head of Department, University of Benin) — Principal investigator
First posted
Oct 20, 2017
Start date
Mar 1, 2017
Primary completion
Sep 30, 2017
Completion
Oct 3, 2017
Last update
Oct 20, 2017

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion